For research and educational purposes only. Not medical advice.
SHLP-2 Reference
Educational, not medical advice reference for SHLP-2: Longevity, Metabolic; regulatory status, evidence posture, source review, and schedule not…
Reference summary
Mouse and cell-model literature suggests roles in energy homeostasis, insulin sensitivity, oxidative stress, and retinal / macular-degeneration models. Human intervention data are absent.
Regulatory and posture
- Categories
- Longevity, Metabolic
- Aliases
- Small humanin-like peptide 2, SHLP2, Mitochondrial-derived peptide
- Evidence posture
- preclinical - Preclinical mitochondrial-derived peptide. Longevity, fat-loss, and metabolic claims are unproven in humans.
- Regulatory status
- No FDA-approved SHLP-2 drug label. SHLP-2 is a mitochondrial-derived peptide studied in preclinical metabolic, aging, oxidative-stress, and eye-disease models.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: SHLP2 mitochondrial-derived peptide energy-homeostasis mouse study
- PubMed: SHLP2 protective effects in macular-degeneration models
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.